Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2025-12-26 @ 6:21 AM
Study NCT ID:
NCT04785794
Status:
COMPLETED
Last Update Posted:
2023-06-15
First Post:
2021-03-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Immunogenicity of the Sing2016 M2SR H3N2 Monovalent Influenza Vaccine in Adults Ages 50 to 85 Years Old
Sponsor:
FluGen Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-30
Start Date Type:
ACTUAL
Primary Completion Date:
2021-11-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-11-30
Completion Date Type:
ACTUAL
First Submit Date:
2021-03-03
First Submit QC Date:
None
Study First Post Date:
2021-03-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-03-13
Results First Submit QC Date:
None
Results First Post Date:
2023-06-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-22
Last Update Post Date:
2023-06-15
Last Update Post Date Type:
ACTUAL